21 CFR 556.292 - Gamithromycin.

§ 556.292 Gamithromycin.

(a)Acceptable Daily Intake (ADI). The ADI for total residues of gamithromycin is 10 micrograms per kilogram of body weight per day.

(b)Tolerances. The tolerances for gamithromycin (the marker residue) are:

(1)Cattle -

(i)Liver (the target tissue): 500 parts per billion (ppb).

(ii)Muscle. 150 ppb.

(2) [Reserved]

(c)Related conditions of use. See § 522.1014 of this chapter.

[ 76 FR 57907, Sept. 19, 2011]

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.

United States Code

Title 21 published on 09-Jun-2018 03:51

The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 556 after this date.

  • 2018-03-30; vol. 83 # 62 - Friday, March 30, 2018
    1. 83 FR 13632 - New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of Sponsorship; Change of a Sponsor's Name and Address
      GPO FDSys XML | Text
      DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration
      Final rule; technical amendments.
      This rule is effective March 30, 2018, except for amendatory instructions 3 to 21 CFR 510.600, 9 to 21 CFR 522.300, 10 to 21 CFR 522.540, and 11 to 21 CFR 522.1081, which are effective April 9, 2018.
      21 CFR Parts 510, 520, 522, 524, 556, and 558
The section you are viewing is cited by the following CFR sections.